Interaction between ion channels and membrane skeleton

离子通道与膜骨架之间的相互作用

基本信息

  • 批准号:
    03833019
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1992
  • 项目状态:
    已结题

项目摘要

The membrane skeleton plays a critical role in a number of biological processes including mobilization of membrane receptors, endocytosis, exocytosis, cell polarity and morphology, cell adhesion, and membrane lipid turnover. Ca^<2+> has profound effects on the membrane skeleton in a variety of cells, and there must exist regulation system(s) of the membrane skeletal proteins by Ca^<2+>. Since Ca^<2+> comes into cells through Ca^<2+> channels, there may be functional interaction between Ca^<2+> channels and the membrane skeleton. In the present study, we focused on a Ca^<2+> - and phospholipid-binding protein, annexin VI, in brain, and examined whether annexin VI is involved in the regulation of membrane skeletal proteins by Ca^<2+>. Annexin VI bound to about 14 proteins in rat brain whole homogenate in a Ca^<2+>/phospholipid-dependent manner. Of these, 5 proteins were enriched in the cytoskeletal fraction, and one of them was identified to be calspectin (brain spectrin or fodrin). When examined with purified calspectin in the native state, the binding of annexin VI to calspectin was also Ca^<2+> - dependent. The Ca^<2+> affinity of the binding (KCa) was about 20 muM. The affinity for annexin VI (Kd) was about 270 nM. Annexin VI bound to beta subunit of calspectin but not to alpha subunit. When the effect of annexin VI on the interaction between F-actin and calspectin was examined by low-shear viscometry, annexin VI inhibited the F-actin cross-linking activity of calspectin in a Ca^<2+>/phospholipid-dependent manner. Cosedimentation assay showed that annexin VI dissociates calspectin from F-actin only in the presence of Ca^<2+> and phospholipid. These results indicate that annexin VI can dissociate and redistribute calspectin in a Ca2+/phospholipid-dependent manner under the plasma membrane, and that annexin VI may regulate the membrane skeleton of neuronal cells in response to Ca^<2+>.
膜骨架在许多生物过程中起关键作用,包括膜受体的动员、内吞作用、胞吐作用、细胞极性和形态、细胞粘附和膜脂质周转。Ca^<2+>对多种细胞的膜骨架有着深刻的影响,一定存在Ca^<2+>对膜骨架蛋白的调控系统。由于Ca^2+是通过Ca^2+通道进入细胞的,因此Ca^2+通道与细胞膜骨架之间可能存在功能性相互作用。在本研究中,我们集中在钙和磷脂结合蛋白,膜联蛋白VI,在大脑中,并检查是否膜联蛋白VI参与调节膜骨架蛋白的Ca^<2+>。膜联蛋白VI以Ca^2+/磷脂依赖性方式与大鼠全脑匀浆中的约14种蛋白质结合。其中,5种蛋白质在细胞骨架组分中富集,其中一种被鉴定为钙网蛋白(脑血影蛋白或胞衬蛋白)。当用天然状态的纯化钙光凝蛋白检测时,膜联蛋白VI与钙光凝蛋白的结合也是Ca^2+依赖性的。结合的Ca^2+亲和力(KCa)约为20 μ M。对膜联蛋白VI的亲和力(Kd)为约270 nM。膜联蛋白VI结合钙斑蛋白的β亚基,但不结合α亚基。当通过低剪切粘度法检测膜联蛋白VI对F-肌动蛋白和钙网蛋白之间相互作用的影响时,膜联蛋白VI以Ca^2+/磷脂依赖性方式抑制钙网蛋白的F-肌动蛋白交联活性。共沉降分析表明,膜联蛋白VI仅在Ca^2+和磷脂存在的情况下才能将钙斑蛋白从F-肌动蛋白上解离。这些结果表明,膜联蛋白VI可以在质膜下以Ca 2 +/磷脂依赖性的方式解离和重新分布钙spectin,并且膜联蛋白VI可以响应于Ca^<2+>调节神经细胞的膜骨架。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kimura,Y.: "Effects of monoclonal antibody against phospholamban on calcium pump ATPase of cardiac sarcoplasmic reticulum." J.Mol.Cell.Cardiol.23. 1223-1230 (1991)
Kimura,Y.:“抗磷蛋白单克隆抗体对心脏肌浆网钙泵 ATP 酶的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inui, M: Japan Scientific Society Press. Annexin VI binding proteins in brain. In Neuronal Cytoskeleton, (1993)
Inui,M:日本科学会出版社。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tanaka,T.: "Ca^<2+>ーDependent of the spectrin/actin interaction by calmodulin and protein 4.1." J.Biol.Chem.266. 1134-1140 (1991)
Tanaka, T.:“Ca^<2+> - 钙调蛋白和蛋白质 4.1 影响血影蛋白/肌动蛋白相互作用。J.Biol.Chem.266 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Radermacher,M.: "Cryo-EM of the native structure of the calcium release channel/ryanodine receptor from sarcoplasmic reticulum." Biophysical Journal. 61. 936-940 (1992)
Radermacher,M.:“肌浆网钙释放通道/兰尼碱受体天然结构的冷冻电镜。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inui,M.: "Molecular machinery of calcium release from cardiac sarcoplasmic reticulum. In Molecular Biology of the Myocardium." CRC Press, 222 (1992)
Inui,M.:“心脏肌浆网钙释放的分子机制。心肌分子生物学。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INUI Makoto其他文献

INUI Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INUI Makoto', 18)}}的其他基金

Ultrastructural analysis of calcium transport system of cardiac sarcoplasmic reticulum for drug development
心脏肌浆网钙转运系统的超微结构分析用于药物开发
  • 批准号:
    17H04033
  • 财政年份:
    2017
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the molecular mechanisms by a cyclic peptide, SEK-1005 promotes skin wound healing
阐明环肽 SEK-1005 促进皮肤伤口愈合的分子机制
  • 批准号:
    16K15203
  • 财政年份:
    2016
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of IGF-1 receptor-independent signaling from IGF-1 and its application for drug development
IGF-1 的 IGF-1 受体非依赖性信号传导分析及其在药物开发中的应用
  • 批准号:
    25670128
  • 财政年份:
    2013
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of a new drug for heart failure targeting phospholamban
以受磷蛋白为靶点的心力衰竭新药的开发
  • 批准号:
    25293062
  • 财政年份:
    2013
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel inotropic and lucitorpic agent for treatment of heart failure
开发用于治疗心力衰竭的新型正性肌力药物和促光亮药物
  • 批准号:
    22390050
  • 财政年份:
    2010
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a new drug for heart failure
开发治疗心力衰竭的新药
  • 批准号:
    14370032
  • 财政年份:
    2002
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of ion channel regulation by a protein-protein interaction
蛋白质-蛋白质相互作用调节离子通道的分子机制
  • 批准号:
    12470019
  • 财政年份:
    2000
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of cytoskeleton by annexin VI
膜联蛋白 VI 对细胞骨架的调节
  • 批准号:
    07680842
  • 财政年份:
    1995
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interaction of annexins with membrane skeletal proteins in brain
膜联蛋白与大脑中膜骨骼蛋白的相互作用
  • 批准号:
    05680676
  • 财政年份:
    1993
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The development of targeterd therapies for Intra-mitochondrial calcium ion dinamics in colorectal cancer stem cells
结直肠癌干细胞线粒体内钙离子动态靶向疗法的开发
  • 批准号:
    23K06654
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CIFS - Calcium Ion Frequency Standard
CIFS - 钙离子频率标准
  • 批准号:
    10004412
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Collaborative R&D
Evaluation of voltage-gated calcium ion channels as a therapeutic target in intrahepatic cholangiocarcinoma
电压门控钙离子通道作为肝内胆管癌治疗靶点的评估
  • 批准号:
    10386735
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Evaluation of voltage-gated calcium ion channels as a therapeutic target in intrahepatic cholangiocarcinoma
电压门控钙离子通道作为肝内胆管癌治疗靶点的评估
  • 批准号:
    10634505
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of a calcium ion channel in collagen remodeling
钙离子通道在胶原重塑中的作用
  • 批准号:
    562159-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
    University Undergraduate Student Research Awards
Collaborative Research: CRCNS Research Proposal: Presynaptic structure-function relationships that control AP waveforms, calcium ion, entry, and transmitter release at NMJs
合作研究:CRCNS 研究提案:控制 NMJ 的 AP 波形、钙离子、进入和递质释放的突触前结构功能关系
  • 批准号:
    2011616
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Standard Grant
Collaborative Research: CRCNS Research Proposal: Presynaptic structure-function relationships that control AP waveforms, calcium ion, entry, and transmitter release at NMJs
合作研究:CRCNS 研究提案:控制 NMJ 的 AP 波形、钙离子、进入和递质释放的突触前结构功能关系
  • 批准号:
    2011645
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Standard Grant
Collaborative Research: CRCNS Research Proposal: Presynaptic structure-function relationships that control AP waveforms, calcium ion, entry, and transmitter release at NMJs
合作研究:CRCNS 研究提案:控制 NMJ 的 AP 波形、钙离子、进入和递质释放的突触前结构功能关系
  • 批准号:
    2011630
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Standard Grant
Collaborative Research: CRCNS Research Proposal: Presynaptic structure-function relationships that control AP waveforms, calcium ion, entry, and transmitter release at NMJs
合作研究:CRCNS 研究提案:控制 NMJ 的 AP 波形、钙离子、进入和递质释放的突触前结构功能关系
  • 批准号:
    2011648
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Standard Grant
SSA - The in situ molecular structure of active calcium ion channels
SSA - 活性钙离子通道的原位分子结构
  • 批准号:
    2238492
  • 财政年份:
    2019
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了